Validation studies for models projecting the risk of invasive and total breast cancer incidence

Journal of the National Cancer Institute

Volumn 91, Issue 18, 1999, Pages 1541-1548

  Costantino, Joseph P ^a,d   Gail, Mitchell H ^b   Pee, David ^c   Anderson, Stewart ^a   Redmond, Carol K ^d   Benichou, Jacques ^d   Wieand, H Samuel ^a  

^a NSABP Foundation Inc   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; CANCER SCREENING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTICENTER STUDY; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0033568691     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.18.1541     Document Type: Article

References (17)

1. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86.
2. Benichou J. A computer program for estimating individualized probabilities of breast cancer [published erratum appears in Comput Biomed Res 1994;27:81]. Comput Biomed Res 1993;26:373-82.
3. Benichou J, Gail MH, Mulvihill JJ. Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 1996;14:103-10.
4. Gail M, Rimer B. Risk-based recommendations for mammographic screening for women in their forties. J Clin Oncol 1998;16:3105-14.
5. Anderson SJ, Ahnn S, Duff K. NSABP Breast Cancer Prevention Trial risk assessment program, version 2. NSABP Biostatistical Center Technical Report, August 14, 1992.
6. Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, et al. Tamoxifen for the prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst 1998;90:1371-88.
7. Breast Cancer Risk Assessment Tool for Health Care Providers. Office of Cancer Communication. Bethesda (MD): National Cancer Institute; 1998.
8. Wingo PA, Ory HW, Layde PM, Lee NC. The evaluation of the data collection process for a multicenter, population-based, case-control design. Am J Epidemiol 1988;128:206-17.
9. Gail MH, Benichou J. Assessing the risk of breast cancer in individuals. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Cancer prevention. Philadelphia (PA): Lippincott; 1992. p. 1-15.
10. Gail MH, Benichou J. Validation studies on a model for breast cancer risk [editorial] [published erratum appears in J Natl Cancer Inst 1 994;86:803]. J Natl Cancer Inst 1994;86:573-5.
11. Bondy ML, Lustbader ED, Halabi S, Ross E, Vogel VG. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994;86:620-5.
12. Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. model for predicting individual breast cancer risk. J Natl Cancer Inst 1994;86:600-7.
13. Cox DR. Regression models and life tables (with discussion). J R Stat Soc, Series B 1972;45:311-54.
14. Kessler LG, Feuer EJ, Brown ML. Projections of the breast cancer burden to U.S. women: 1990-2000. Prev Med 1991;20:170-82.
15. Miller BA, Kolonel LN, Bernstein L, Young JL Jr, Swanson GM, West D, et al., editors. Racial/ethnic patterns of cancer in the United States, 1988-1992. Bethesda (MD): National Institutes of Health, National Cancer Institute; 1996 Report No.: DHHS Publ No. (NIH)96-4104.
16. Lerman C, Lustbader E, Rimer B, Daly M, Miller S, Sands C, et al. Effects of individualized breast cancer risk counseling: a randomized trial. J Natl Cancer Inst 1995;87:286-92.
17. Black WC, Nease RF Jr, Tosteson AN. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst 1995;87:720-31.